Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

por Rangaka, Molebogeng X, Hamada, Yohhei, Abubakar, Ibrahim
Publicado 2022

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials

por Abubakar, Ibrahim, Cobelens, Frank G. J., Rangaka, Molebogeng X.
Publicado 2020

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis

por Gupta-Wright, Ankur, Tomlinson, Gillian S, Rangaka, Molebogeng X, Fletcher, Helen A
Publicado 2018

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment

por Riou, Catherine, Jhilmeet, Nishtha, Rangaka, Molebogeng X, Wilkinson, Robert J, Wilkinson, Katalin A
Publicado 2020

A user-centred design framework for mHealth

por Farao, Jaydon, Malila, Bessie, Conrad, Nailah, Mutsvangwa, Tinashe, Rangaka, Molebogeng X., Douglas, Tania S.
Publicado 2020

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence

por Hamada, Yohhei, Fong, Christopher J, Copas, Andrew, Hurst, John R, Rangaka, Molebogeng X
Publicado 2021

Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression

por Lowe, David M., Rangaka, Molebogeng X., Gordon, Fabiana, James, Chris D., Miller, Robert F.
Publicado 2013

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria...

por Mendelson, Fiona, Griesel, Rulan, Tiffin, Nicki, Rangaka, Molebogeng, Boulle, Andrew, Mendelson, Marc, Maartens, Gary
Publicado 2018

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges

por Naidoo, Pren, Theron, Grant, Rangaka, Molebogeng X, Chihota, Violet N, Vaughan, Louise, Brey, Zameer O, Pillay, Yogan
Publicado 2017

Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization’s algorithm for seriously ill HIV-infected patients

por Maartens, Gary, Stewart, Annemie, Griesel, Rulan, Kengne, Andre P., Dube, Felix, Nicol, Mark, Rangaka, Molebogeng X., Mendelson, Marc
Publicado 2018

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis

por Gupta, Rishi K, Turner, Carolin T, Venturini, Cristina, Esmail, Hanif, Rangaka, Molebogeng X, Copas, Andrew, Lipman, Marc, Abubakar, Ibrahim, Noursadeghi, Mahdad
Publicado 2020

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome

por Skolimowska, Keira H., Rangaka, Molebogeng X., Meintjes, Graeme, Pepper, Dominique J., Seldon, Ronnett, Matthews, Kerryn, Wilkinson, Robert J., Wilkinson, Katalin A.
Publicado 2012

Role of the Interleukin 10 Family of Cytokines in Patients With Immune Reconstitution Inflammatory Syndrome Associated With HIV Infection and Tuberculosis

por Tadokera, Rebecca, Wilkinson, Katalin A., Meintjes, Graeme A., Skolimowska, Keira H., Matthews, Kerryn, Seldon, Ronnett, Rangaka, Molebogeng X., Maartens, Gary, Wilkinson, Robert J.
Publicado 2013

Tracking COVID-19 using online search

por Lampos, Vasileios, Majumder, Maimuna S., Yom-Tov, Elad, Edelstein, Michael, Moura, Simon, Hamada, Yohhei, Rangaka, Molebogeng X., McKendry, Rachel A., Cox, Ingemar J.
Publicado 2021

The impact of COVID-19 on global tuberculosis control

por Lipman, Marc, McQuaid, C. Finn, Abubakar, Ibrahim, Khan, Mishal, Kranzer, Katharina, McHugh, Timothy D., Padmapriyadarsini, Chandrasekaran, Rangaka, Molebogeng X., Stoker, Neil
Publicado 2021

Population tailored modification of tuberculosis specific interferon-gamma release assay

por Horvati, Kata, Bősze, Szilvia, Gideon, Hannah P., Bacsa, Bernadett, Szabó, Tamás G., Goliath, Rene, Rangaka, Molebogeng X., Hudecz, Ferenc, Wilkinson, Robert J., Wilkinson, Katalin A.
Publicado 2016

Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus–1

por Lesosky, Maia, Rangaka, Molebogeng X, Pienaar, Cara, Coussens, Anna K, Goliath, Rene, Mathee, Shaheed, Mwansa-Kambafwile, Judith, Maartens, Gary, Wilkinson, Robert J, Wilkinson, Katalin Andrea
Publicado 2019

Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape

por Hamada, Yohhei, Penn-Nicholson, Adam, Krishnan, Sriram, Cirillo, Daniela Maria, Matteelli, Alberto, Wyss, Romain, Denkinger, Claudia M., Rangaka, Molebogeng X., Ruhwald, Morten, Schumacher, Samuel G.
Publicado 2022

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population

por Ige, Fehintola, Hamada, Yohhei, Steinhardt, Laura, Iriemenam, Nnaemeka C., Uwandu, Mabel, Greby, Stacie Marta, Aniedobe, Maureen, Salako, Babatunde Lawal, Rangaka, Molebogeng X., Abubakar, Ibrahim, Audu, Rosemary
Publicado 2021

A Systematic Review on the Safety of Mycobacterium tuberculosis–Specific Antigen–Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin Tests

por Hamada, Yohhei, Kontsevaya, Irina, Surkova, Elena, Wang, Ting Ting, Wan-Hsin, Liu, Matveev, Aleksandr, Ziganshina, Liliya Eugenevna, Denkinger, Claudia M, Korobitsyn, Alexei, Ismail, Nazir, Abubakar, Ibrahim, Rangaka, Molebogeng X
Publicado 2023